Genome-wide association study of primary open-angle glaucoma in continental and admixed African populations. by Bonnemaijer, Pieter WM et al.
UC San Diego
UC San Diego Previously Published Works
Title
Genome-wide association study of primary open-angle glaucoma in continental and 
admixed African populations.
Permalink
https://escholarship.org/uc/item/5t70566t
Journal
Human genetics, 137(10)
ISSN
0340-6717
Authors
Bonnemaijer, Pieter WM
Iglesias, Adriana I
Nadkarni, Girish N
et al.
Publication Date
2018-10-13
DOI
10.1007/s00439-018-1943-7
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Genome-wide association study of primary open-angle 
glaucoma in continental and admixed African populations
Pieter W. M. Bonnemaijer1,2,3, Adriana I. Iglesias1,2,4, Girish N. Nadkarni5,6, Anna J. 
Sanyiwa7, Hassan G. Hassan8, Colin Cook9, GIGA Study Group, Mark Simcoe10, Kent D. 
Taylor11, Claudia Schurmann5, Gillian M. Belbin5,12, Eimear E. Kenny5,12,13,14, Erwin P. 
Bottinger5, Suzanne van de Laar15, Susan E. I. Wiliams16, Stephen K. Akafo17, Adeyinka O. 
Ashaye18, Linda M. Zangwill19, Christopher A. Girkin20, Maggie C. Y. Ng21, Jerome I. 
Rotter11, Robert N. Weinreb19, Zheng Li22, R. Rand Allingham23, Eyes of Africa Genetics 
Consortium, Abhishek Nag10, Pirro G. Hysi10, Magda A. Meester-Smoor1,2, Janey L 
Wiggs24, NEIGHBORHOOD Consortium, Michael A. Hauser23,25, Christopher J. 
Hammond10, Hans G. Lemij26, Ruth J. F. Loos5,27, Cornelia M. van Duijn2, Alberta A. H. J. 
Thiadens1,2, Caroline C. W. Klaver1,2,28
1Department of Ophthalmology, Erasmus MC, Rotterdam, The Netherlands 2Department of 
Epidemiology, Erasmus MC, Rotterdam, The Netherlands 3The Rotterdam Eye Hospital, 
Rotterdam, The Netherlands 4Department of Clinical Genetics, Erasmus MC, Rotterdam, The 
Netherlands 5The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine 
at Mount Sinai, New York, NY, USA 6Division of Nephrology, Department of Medicine, Icahn 
School of Medicine at Mount Sinai, New York, USA 7Department of Ophthalmology, Muhimbili 
University of Health and Allied Sciences/Muhimbili National Hospital, Dar es Salaam, Tanzania 
8Department of Ophthalmology, Comprehensive Community Based Rehabilitation in Tanzania 
(CCBRT) Hospital, Dar es Salaam, Tanzania 9Division of Ophthalmology, University of Cape 
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you 
give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes 
were made.
Caroline C. W. Klaver, c.c.w.klaver@erasmusmc.nl. 
The members of GIGA Study Group, Eyes of Africa Genetics Consortium, NEIGHBORHOOD Consortium are listed in Electronic 
Supplementary material.
Electronic supplementary material The online version of this article (https://doi.org/10.1007/s00439-018-1943-7) contains 
supplementary material, which is available to authorized users.
Conflict of interest On behalf of all authors, the corresponding author states that there is no conflict of interest.
URLs
BioMe (2018) http://icahn.mssm.edu/research/ipm/programs/biome-biobank
EPACTS (2018) https://genome.sph.umich.edu/wiki/EPACTS
GCTA (2018) http://cnsgenomics.com/software/gcta/#Overview
Genetic Type I Error Calculator (2018) http://grass.cgs.hku.hk/gec/index.php
METAL (2018) https://genome.sph.umich.edu/wiki/METAL
METASOFT (2018) http://genetics.cs.ucla.edu/meta/
Michigan Imputation Server (2018) https://imputationserver.sph.umich.edu/start.html
Plink v 1.9.0 (2018) https://www.cog-genomics.org/plink2
Plink v.1.07 (2018) http://zzz.bwh.harvard.edu/plink/index.shtml
SNPTEST (2018) https://mathgen.stats.ox.ac.uk/genetics_software/snptest/snptest.html
The Ocular Tissue Database (2018) https://genome.uiowa.edu/otdb/ VEGAS2 (2018) https://vegas2.qimrberghofer.edu.au/
HHS Public Access
Author manuscript
Hum Genet. Author manuscript; available in PMC 2019 September 21.
Published in final edited form as:
Hum Genet. 2018 October ; 137(10): 847–862. doi:10.1007/s00439-018-1943-7.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Town, Cape Town, South Africa 10Department of Twin Research and Genetic Epidemiology, 
King’s College London, London, UK 11Department of Pediatrics, The Institute for Translational 
Genomics and Population Sciences, Los Angeles Biomedical Research Institute, Harbor-UCLA 
Medical Center, Torrance, CA, USA 12Genetic and Genomic Sciences, Icahn School of Medicine 
at Mount Sinai, New York, NY, USA 13The Center for Statistical Genetics, Icahn School of 
Medicine at Mount Sinai, New York, NY, USA 14The Institute for Genomics and Multiscale Biology, 
Icahn School of Medicine at Mount Sinai, New York, NY, USA 15Department of Ophthalmology, 
University Medical Center, Utrecht, The Netherlands 16Division of Ophthalmology, Department of 
Neurosciences, University of the Witwatersrand, Johannesburg, South Africa 17Unit of 
Ophthalmology, Department of Surgery, University of Ghana School of Medicine and Dentistry, 
Accra, Ghana 18Department of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, 
Nigeria 19Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, 
University of California San Diego, La Jolla, CA, USA 20Department of Ophthalmology, University 
of Alabama at Birmingham School of Medicine, Birmingham, AL, USA 21Department of 
Biochemistry, Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, 
NC, USA 22Genome Institute of Singapore, Singapore, Singapore 23Department of 
Ophthalmology, Duke University, Durham, NC, USA 24Department of Ophthalmology, Harvard 
Medical School, Boston, MA, USA 25Department of Medicine, Duke University Medical Center, 
Durham, NC, USA 26Glaucoma Service, The Rotterdam Eye Hospital, Rotterdam, The 
Netherlands 27The Mindich Child Health and Development Institute, Icahn School of Medicine at 
Mount Sinai, New York, NY, USA 28Department of Ophthalmology, Radboud University Medical 
Center, Nijmegen, The Netherlands
Abstract
Primary open angle glaucoma (POAG) is a complex disease with a major genetic contribution. Its 
prevalence varies greatly among ethnic groups, and is up to five times more frequent in black 
African populations compared to Europeans. So far, worldwide efforts to elucidate the genetic 
complexity of POAG in African populations has been limited. We conducted a genome-wide 
association study in 1113 POAG cases and 1826 controls from Tanzanian, South African and 
African American study samples. Apart from confirming evidence of association at TXNRD2 
(rs16984299; OR[T] 1.20; P = 0.003), we found that a genetic risk score combining the effects of 
the 15 previously reported POAG loci was significantly associated with POAG in our samples (OR 
1.56; 95% CI 1.26–1.93; P = 4.79 × 10−5). By genome-wide association testing we identified a 
novel candidate locus, rs141186647, harboring EXOC4 (OR[A] 0.48; P = 3.75 × 10−8), a gene 
transcribing a component of the exocyst complex involved in vesicle transport. The low frequency 
and high degree of genetic heterogeneity at this region hampered validation of this finding in 
predominantly West-African replication sets. Our results suggest that established genetic risk 
factors play a role in African POAG, however, they do not explain the higher disease load. The 
high heterogeneity within Africans remains a challenge to identify the genetic commonalities for 
POAG in this ethnicity, and demands studies of extremely large size.
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Introduction
Glaucoma is the leading cause of irreversible blindness worldwide (Tham et al. 2014). The 
disease is an optic neuropathy characterized by loss of retinal ganglion cells resulting in 
peripheral visual field defects. Later in the disease process, the visual field defects may 
involve central vision leading to blindness. Primary open-angle glaucoma (POAG) is the 
commonest subtype of glaucoma. Intraocular pressure (IOP), family history, age, and 
ancestry are established risk factors. In particular persons of African ancestry have 3–5 × 
increased risk of POAG, and have a more severe course of disease with a higher risk of 
blindness (Cook 2009; Kyari et al. 2013). This ethnic predilection along with the familial 
nature strongly suggests that genetic factors contribute to the pathogenesis of POAG.
Recently, progress has been made in the identification of associated variants using linkage 
analysis and genome-wide association studies (GWAS). Rare variants with large effects have 
been identified in MYOC and OPTN, common variants with smaller effect have been 
reported in genomic regions that include CAV1-CAV2, CDC7-TGFRB3, TMCO1, 
CDKN2B-AS1, ABCA1, AFAP1, GMDS, TXNRD2, ATXN2, FOXC1, GAS7, 
ARHGEF12, SIX6, 8q22 and PMM2 (Bailey et al. 2016; Burdon et al. 2011; Chen et al. 
2014; Liu et al. 2013; Hysi et al. 2014; Li et al. 2015; Springelkamp et al. 2015; 
Thorleifsson et al. 2010; Wiggs et al. 2012). However, these loci explain only 5–10% of 
cases, leaving the heritability of POAG largely unexplained. Most genetic studies were 
predominantly conducted in European and Asian populations, leaving African ancestry 
underrepresented up to now. Recent studies in Africans or in cohorts of African descent (i.e., 
Ghana, South Africa and in African Americans) could not replicate most of the loci 
previously identified in GWAS of European and Asian populations (Cao et al. 2012; Liu et 
al. 2013; Williams et al. 2015).
Gene finding can be more effective in study populations where the disease is more common, 
of earlier onset and more severe. Therefore, in this study, we conducted a genome-wide 
meta-analysis using African black and South African colored POAG cases and controls, 
from the Genetics In Glaucoma patients from African descent study (GIGA) recruited at 
hospitals from South Africa and Tanzania and African Americans enrolled in the BioMe 
(2018) biobank.
Results
The GIGA dataset consisted of 444 participants from South Africa (NPOAG = 297; Ncontrol = 
147) and 695 participants from Tanzania (NPOAG = 366; Ncontrol = 329). The Tanzanian 
participants were all from the black African origin, 38% of South African participants were 
also from black African origin while the remaining 62% were self-reported South African 
Coloured (European, African, Asian admixed). The BioMe dataset consisted of POAG cases 
(N = 450) and controls (N = 1350) and were all African American. The clinical and 
demographic characteristics of the GIGA and BioMe participants have been summarized in 
Table 1.
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Association of previously reported POAG loci in African populations
First, we tested the association of the 15 previously established POAG SNPs identified in 
GWAS of European and Asian populations in the GIGA and BioMe datasets (Bailey et al. 
2016; Burdon et al. 2011; Chen et al. 2014; Liu et al. 2013; Hysi et al. 2014; Li et al. 2015; 
Springelkamp et al. 2015; Thorleifsson et al. 2010; Wiggs et al. 2012). None of these SNPs 
replicated at a nominal significance level (P < 0.05) in any single ethnicity (Supplementary 
Table 1), nor in a combined analysis (Table 2 exact replication). Because linkage 
disequilibrium (LD) patterns may differ between the study populations of the reported 
GWAS and the current African study participants, we also searched for evidence of 
transferability of the SNPs. Locuszoom plots were made using the LD pattern of Europeans 
and Asians (1000Genomes) to investigate whether SNPs in high LD (r2 > 0.8) with the 
original lead SNP showed evidence of association in our study (Supplementary Fig. 1). This 
“local” replication strategy queried a 500 kb window centered on the lead SNP, and yielded 
a total of 246 SNPs in LD (r2 > 0.8) with the 15 lead SNPs. Of these 246 SNPs, three SNPs 
in the TXNRD2, CDKN2B-AS1, and TMCO1 loci were significantly associated with POAG 
in our study (P < 0.05) (Table 2, local replication), rs16984299 in TXNRD2 had similar 
effect size as reported by Cook Bailey et al.(Bailey et al. 2016) and survived multiple testing 
(OR[T] 1.20; 95% CI 1.06–1.35; PBonferonni = 0.049) when the association was corrected for 
the effective number of SNPs (N = 16) in the queried 500 kb window. In addition, we also 
analyzed three independent POAG variants found in African Americans from the Women 
Health Initiative (Hoffmann et al. 2014). We found rs192917960 at the RBFOX1 locus 
associated with POAG in BioMe (P = 0.02, Supplementary Table 2), but this association did 
not withstand correction for multiple testing.
Next, we compared effect sizes from the combined analysis of GIGA and BioMe with the 
effect sizes from published GWAS reports. In total, 12 out of the 15 known lead SNPs had a 
consistent direction of effect (Supplementary Fig. 2). Allele frequencies for most SNPs were 
very similar in South African blacks, Tanzanian, and African American datasets, but 
markedly different compared with the European and Asian studies (Supplementary Fig. 3). 
In eight of the 15 SNPs, the effect allele had a considerable higher frequency in Africans 
while five were clearly less frequent compared to Europeans.
To study the contribution of the known SNPs to the risk of POAG in GIGA, we calculated a 
multilocus Genetic Risk Score (GRS) based on 15 known SNPs. Three known SNPs for 
TXNRD2, CDKN2B-AS1, and TMCO1 were replaced by the proxies that were identified by 
the local replication approach described above. Scores were weighted based on the effect 
sizes found in the GWAS meta-analysis of European populations. The GRS, adjusted for 
age, sex, and first five principal components were associated with POAG in the GIGA 
sample (OR 1.56; 95% CI 1.26–1.93; P = 4.85 × 10−5). We then stratified the GRS in 
quintiles, and estimated the risk of POAG for each quintile relative to the lowest one (Fig. 
1). Trend analysis showed a significant stepwise increase in the risk of POAG per quintile 
(Ptrend = 2.81 × 10−5), with a twofold increase in POAG risk for the highest quintile 
compared to the lowest. The risk attributed to genetics was calculated in reference to the 
mean genetic risk score in the controls. We found that these 15 known variants taken all 
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together attributed 4% (95% CI 2–6%) to the overall POAG risk in this study population 
when we adjusted for age, sex and principal components.
Discovery (stage 1)
To identify new loci associated with POAG in African populations, we performed GWAS 
using our African ancestry datasets. The scheme of the study design is depicted in Fig. 2. In 
the discovery stage, we meta-analyzed GWAS results from the GIGA study (South Africa 
and Tanzania) and BioMe (African American) including in total 1113 POAG cases and 1826 
controls. A total of 13.8 million SNPs were available after applying our QC and filtering 
criteria (see “Methods” section). The genomic inflation factor was 0.94 (SE 1.49 × 10−6) and 
the quantile–quantile plot did not show any systemic inflation in the association results, 
suggesting that confounding by cryptic population stratification was unlikely 
(Supplementary Fig. 4). The discovery association results across the whole genome are 
shown in Fig. 3. We identified one novel region reaching genome-wide significance (P < 5 × 
10−8) in the discovery stage, and two suggestive regions (P < 1 × 10−6) (Table 3). The top 
newly associated SNPs were rs141186647[A] an intronic variant in EXOC4 on chromosome 
7 (OR 0.48; P = 3.15 × 10−8), rs9475699[A] downstream of DST on chromosome 6 (OR 
1.65; P = 1.25 × 10−7), and rs62023880[A] upstream of MNS1 on chromosome 15 (OR 
1.39; P = 5.12 × 10−7). The regional association plots for these three SNPs are shown in Fig. 
4. We did not observe any significant heterogeneity for these SNPs in the meta-analysis of 
GIGA and BioMe. The association results per ethnic group are provided in Supplementary 
Table 2, showing similar effects in Tanzanians, South Africans, and African Americans. 
Conditional and joint analyses did not identify any additional independent signals within the 
set of SNPs reaching P < 1 × 10−6. Additionally, we explored if haplotypes encompassing 
any of the three top SNPs were associated with POAG in GIGA BioMe, the results for this 
haplotype association analysis are provided in Supplementary Table 3.
Replication of associated variants in African populations (stage 2 and stage 3)
All SNPs reaching P < 1 × 10−6 in stage 1 were followed-up in a replication (stage 2) 
comprising four independent African ancestral studies from South Africa, Ghana, Nigeria 
and African Americans (Eyes of Africa Genetic Consortium; Ncases = 2320; Ncontrols = 
2121), the South London POAG case–control cohort comprising individuals from West 
African origin (Ncases = 378; Ncontrols = 217) and The African Descent and Glaucoma 
Evaluation Study (ADAGES) including African Americans (Ncases = 1890; Ncontrols = 
2205). In total, 22 SNPs at the three independent loci were brought forward for replication. 
Variant rs9475699 (downstream of DST) reached a nominal level of statistical significance 
(OR 1.19, P = 0.032) in the Ghanaian study population (Supplementary Table 4). We then 
performed a meta-analysis of all six replication datasets (stage 2), first using a fixed effects 
model, and found no statistical significant replication (Table 4). Subsequent meta-analysis 
by means of the Han and Eskin random-effects model for SNPs with significant (P < 0.05) 
heterogeneity, also did not identify any SNPs with significant association. In stage 3, we 
performed a meta-analysis of all studies (stage 1 + stage 2), totaling 5701 POAG cases and 
6369 controls. Given the high degree of heterogeneity observed in the fixed effect meta-
analysis at this stage, we performed Han and Eskin random-effects model. Neither fixed 
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effects nor Han and Eskin random-effect meta-analysis resulted in genome-wide significant 
signals (Table 4, Supplementary Table 4 and Supplementary Fig. 5).
Cross-ethnic validation
We further investigated to what extent loci found in our African ancestry GWAS confer a 
risk of POAG in Europeans. We investigated the top three ranked loci from the discovery 
stage in two independent European ancestry studies from the National Eye Institute 
Glaucoma Human Genetics Collaboration (NEIGHBOR) and the Massachusetts Eye and 
Ear Infirmary (MEEI) (totaling 2606 POAG cases and 2606 controls) with imputed genotype 
data using the Haplotype Reference Consortium (HRC) (McCarthy et al. 2016). 
rs141186647 (EXOC4) and rs9475699 (COL21A1-DST) are rare in the European cohorts 
but had excellent imputation scores (MAF 0.00019, r2 0.987; and MAF 0.0023, r2 0.963, 
respectively). However, neither SNP demonstrated significant association in the European 
datasets (rs141186647 OR[A] 5.09; P = 039; rs9475699 OR[A] 1.27; P = 0.59). SNP 
rs62023880 (MNS1-ZNF280D) on chromosome 15, which was a common variant in the 
NEIGHBOR/MEEI sample (MAF = 0.15,) also did not show statistically significant 
replication (OR 0.947; P = 0.34).
Bioinformatical lookup of functional and regulatory effects and expression of POAG-
associated SNPs
We explored the functional and regulatory annotations of the three lead SNPs found in the 
discovery stage, including proxy-SNPs within high LD (r2 > 0.8 in 1000G AFR). The 
significant top hit rs141186647 at 7q33 represented an intronic variant within the Exocyst 
Complex Component 4 gene (EXOC4). The locus contains a set of SNPs in high LD that 
reside within the introns and within exon 15 (rs34608222; synonymous) of EXOC4 of which 
only rs79198429 (r2 = 0.92 with rs141186647) is annotated as possibly disrupting; 
transcription factor binding (Regu-lomeDB score 3a; Supplementary Table 5). This variant is 
located inside a region annotated as an enhancer histone mark in multiple tissues by the 
RoadMap Epigenomics project, which is predicted to bind the transcriptional coactivator 
protein P300, and to alter five binding motifs including AP-1 transcription factor (Roadmap 
Epigenomics et al. 2015). None of the explored SNPs in this region were associated with 
eQTL’s.
In silico analyses of SNPs correlated with rs9475699 located 21 kb downstream the DST 
gene and rs62023880 neighboring MNS1 gene did not identify any markers with evidence 
for gene regulatory effects.
To assess the expression of the annotated genes in human eye tissues, we examined the 
online Ocular Tissue Database (https://genome.uiowa.edu/otdb/) (Wagner et al. 2013). 
Expression of EXOC4, DST and MNS1 was observed in tissues relevant to POAG, such as 
the trabecular meshwork, optic nerve head and optic nerve. Supplementary Table 6 depicts 
the differences in expression levels of these three genes across tissue types. In the optic 
nerve head, the highest level of expression was found for DST gene (PLIER 632.5).
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Gene-based tests
We performed gene-based tests using VEGAS2 (2018) on the GIGA BioMe meta-analysis 
results, and first investigated the 15 known POAG genes. None of these were significant at a 
nominal statistical level, the smallest P value was found for FOXC1 (P = 0.103, nSNPs = 
573) (Supplementary Table 7). We subsequently explored the gene-based test results of a 
total of 25,590 autosomal genes, using a Bonferroni corrected gene-based significance 
threshold of Pgene–based< 1.95 × 10−6 (0.05/25590). The EXOC4 gene (P = 3.10 × 10−5) did 
not withstand Bonferroni correction.
Discussion
To date, only European and Asian ancestry GWA studies have contributed to the 15 
currently known genetic loci for POAG. Although the frequency of POAG in persons from 
African descent is high compared to those of European or Asian descent, studies of 
individuals of African descent are missing so far. The current study focuses on filling this 
gap. In this case–control study consisting of Africans from the African continent as well as 
of African Americans, we confirmed three POAG loci (CDKN2B-AS1, TMCO1, TXNRD2) 
at nominal significance that were previously found in Europeans, and report one novel 
candidate locus (EXOC4). A variant (rs1063192) near CDKNB2-AS1 has previously been 
shown in the Afro-Caribbean population of Barbados, although this study could not replicate 
other known putative loci (Cao et al. 2012). Another insight gained from the current study 
was that the “local approach” rather than exact replication yielded these replicable findings 
in Africans. Interestingly, these proxy SNPs in Africans have a very similar effect size 
compared to the lead SNP in European GWAS.
This study has strengths and limitations. Of particular strength was the Pan-African origin of 
the study participants. Previous studies from the African continent were smaller and they all 
focused mainly on West Africans. Our study is the first genetic analysis which included East 
Africans. A probable disadvantage of applying a Pan-African approach must also be 
considered. The high genetic diversity present across African populations, even when they 
are geographically close, may reduce the likelihood of reproducing associations in multi-
center studies. Other strengths were the careful diagnosis of cases, the strict criteria for 
controls, and the application of local replication. Optic discs were graded in an objective 
manner from fundus photographs by glaucoma experts using internationally accepted 
standards (Foster et al. 2002). Controls underwent the same review process as cases and had 
to be over 50 years of age to increase the diagnostic certainty of non-disease status. The 
limitations of our study include the relatively low power to detect genome-wide significance 
for small effect sizes, as reflected by the genomic inflation factor < 1.0, and the lack of a 
replication set from East Africa.
As the genome of African populations is much older, genetic diversity is increased, and LD 
across loci is decreased. Rather than focusing only on the lead SNPs from European/Asian 
GWAS, we considered all variants that were in strong European/Asian LD with the lead 
SNPs. We analyzed these variants in our African samples, and found evidence for nominal 
replication of three SNPs in TMCO1 (rs28504591), CDKN2B-AS1 (rs10712703), and 
TXNRD2 (rs16984299), of which the latter withstood Bonferroni correction for the number 
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of effective SNPs. The most significant SNP identified in GWAS is often not the causal 
variant (McCarthy and Hirschhorn 2008). We found similar effect sizes compared to the 
European GWAS for the three SNPs identified by the local replication approach. The overall 
weaker LD structure in Africans favors proximity of these proxy SNPs to the true causal 
variant. This makes it more likely that these proxies are functional. We, therefore, 
recommend candidate gene studies in African populations that failed to replicate known 
disease loci found in European or Asian populations to use this local approach.
Although this study found evidence that at least one known POAG gene plays a role in 
African glaucoma, we could not significantly replicate the remaining 14 associated SNPs 
even when we applied the local approach. Yet our GRS that was based on known European 
and Asian POAG SNPs showed a significant trend (P = 2.81 × 10−5) and a twofold increase 
in POAG risk comparing extreme risk groups. Of note, the allele frequency distributions for 
these SNPs differed markedly between our African study and the original European/Asian 
studies. This points towards differences in genetic architecture, and makes it difficult to 
estimate statistical power.
This study identified a novel candidate variant within the EXOC4 gene in the meta-analysis 
of GIGA and BioMe. Recent reports provide evidence that this gene is implicated in 
cognitive traits as intelligence and educational attainment, and is also associated with the 
neurodegenerative Alzheimer’s disease (Okbay et al. 2016; Sherva et al. 2014; Sniekers et 
al. 2017). The EXOC4 gene is ubiquitously expressed, and is particularly abundant in the 
brain. EXOC4 encodes the SEC-8 protein, a component of a complex which is essential for 
exocytosis; it directs Golgi-derived secretory vesicles to specific docking sites on the plasma 
membrane. Exocyst proteins are needed for rapid membrane expansion, which happens 
during outgrowth of neurons and synaptogenesis. So far, the exocyst complex has not been 
studied in connection with glaucomatous optic neuropathy, however, it is expressed in the 
trabecular meshwork. In this tissue, it plays a role in the formation of invadopodia, 
protrusions that are important for releasing matrix metalloproteinase into the extracellular 
matrix to decrease trabecular outflow resistance (Han et al. 2013). Strikingly, our African 
POAG cases had high IOP, and it is intriguing to speculate that EXOC4 contributes to POAG 
by interfering with matrix metalloproteinase release and trabecular outflow.
Replication of our genome-wide significant finding from the discovery set in our other 
African studies was challenging for this relatively rare variant. Meta-analysis of the 
discovery and replication stage showed considerable variation in effect size and direction of 
effect between the discovery and the replication set, indicating substantial heterogeneity. 
This heterogeneity is likely to be caused by differences in genetic ancestry as most of the 
replication studies were from the West-African origin, while the population GIGA BioMe 
included a substantial proportion of persons from East Africa. Differences in LD pattern 
between causal variants and identified markers as shown in Supplementary Fig. 7 can cause 
this directionally inconsistent association across studies more commonly known as the flip-
flop phenomenon (Lin et al. 2007).
In conclusion, we conducted the first GWAS of POAG comprising continental Africans. We 
verified the European glaucoma gene TXNRD2 and identified a novel candidate locus 
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encompassing EXOC4 that requires further follow up in large African studies. A GRS 
combining the effects of the known POAG SNPs indicated that these SNPs are implicated to 
play a role in African POAG. Future studies on POAG in Africa should take the substantial 
genetic heterogeneity into account by ascertaining large discovery and replication sets from 
the same geographic area.
Methods
Study population
The Genetics In Glaucoma patients from African descent study (GIGA) is a multicenter 
case–control study comprising POAG patients and controls from South Africa and Tanzania. 
Participants from Black African and South African Coloured ancestry were ascertained from 
the ophthalmology outpatient department of the Groote Schuur Hospital in Cape Town, 
South Africa (Ncases = 327; Ncontrols= 194), and from hospitals in Tanzania: Muhimbili 
National Hospital and CCBRT Disability Hospital in Dar es Salaam (Ncases = 395; Ncontrols 
= 382). The study was conducted according to the guidelines for human research by the 
National Institute for Medical Research in Tanzania. Ethical approval was obtained from the 
institutional review boards at each study site, and written informed consent was provided by 
each participant.
The Charles Bronfman Institute for Personalized Medicine BioMe BioBank is an electronic 
medical record (EMR)-linked clinical care biobank that integrates research data and clinical 
care information of patients at The Mount Sinai Medical Center New York. This center 
serves diverse local communities of upper Manhattan with broad health disparities including 
POAG. The current analysis includes participants who self-reported to be of African 
ancestry (Ncases = 450; Ncontrols= 1350) who were enrolled between September 2007 and 
October 2014. Ethical approval was obtained from the institutional review boards at Mount 
Sinai, and written informed consent was obtained from all participants.
Phenotype definition
In GIGA, POAG cases met category 1 or 2 of the ISGEO classification for open-angle 
glaucoma (Foster et al. 2002). In brief, cases had either a definite visual field defect and 
Vertical Cup Disc Ratio (VCDR) ≥ 0.7, or VCDR > 0.8 in the absence of a visual field test. 
Other inclusion criteria were an open angle on gonioscopy and age of onset older than 35 
years. Glaucoma patients diagnosed with secondary causes were excluded from this study. 
Controls were recruited at the same ophthalmology clinics and underwent identical 
examinations as the POAG cases. Inclusion criteria were: no signs of glaucoma, IOP ≤ 21 
mmHg; VCDR< 0.5, and a VCDR inter-eye asymmetry < 0.2, no family history of 
glaucoma, and age > 55 years. Case and control status was adjudicated by two experienced 
ophthalmologists (AT and HL).
In BioMe information on POAG status, sex, age was derived from patients’ EMR. POAG 
patients were considered cases if they had ≥ 1 diagnoses for POAG (ICD-9 codes 365.01, 
365.05, 365.11, 365.12 or ICD-10 code H40.11). Participants with pre-glaucoma (ICD-9 
code 365), ocular hypertension only (ICD-9 code 365.04), unspecified glaucoma (ICD-9 
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code 365.10) or with secondary glaucoma (Supplementary Table 8) were excluded from the 
analyses. Details of the ICD-9 or ICD-10 codes used can be found in Supplementary Table 
9. Controls were those of African ancestry over 40 years of age not being diagnosed with 
any type of glaucoma.
Genotyping
In GIGA, 1162 participants were genotyped using either the Illumina 
HumanOmniExpressExome Beadchip (964,193 variants; Illumina, Inc., San Diego, CA, 
USA; n = 999) or the Illumina HumanOmni2.5Exome Beadchip (2,406,945 variants; 
Illumina, Inc., San Diego, CA, USA; n = 163). Extensive quality control (QC) was 
performed on the genotyped data in PLINK v1.07 (Purcell et al. 2007). Variants with a call 
rate < 95%, as well as variants showing an extreme deviation from Hardy–Weinberg 
equilibrium (P < 1 × 10−6), or MAF < 0.01 were excluded. All SNPs were mapped to 
genome build hg19/GRCh37. Individual level QC was performed by exclusion of individuals 
with a call rate < 95%, discordant sex in self-report versus genetically determined sex, 
excess or reduced heterozygosity, relatedness (PI-HAT > 0.25) or duplicative samples based 
on identity by descent (IBD) sharing calculations. The final dataset consisted of 663 and 476 
successfully genotyped POAG cases and controls, respectively.
Participants from BioMe were genotyped on either Illumina HumanOmniExpressExome-8 
v1.0 beadchip array or the illumina Multi-Ethnic Genotyping Array (MEGA). As in GIGA, 
QC was performed following a similar protocol. Exclusion of variants was based on a call 
rate < 95%, extreme deviation from Hardy–Weinberg equilibrium (P < 1 × 10−5), or MAF < 
0.01. Individual level QC excluded samples with a call rate < 95%, gender mismatches, 
ethnic outliers, excess or reduced heterozygosity and first degree relatives or duplicates.
Imputation
Imputation of unknown genetic variation was performed by means of the “cosmopolitan” 
approach of using all available populations in a reference panel. The 1000 Genomes Project 
phase III version 5 was used as an imputation reference panel for GIGA (Genomes Project et 
al. 2015). The pipeline implemented at the Michigan Imputation Server (https://
imputationserver.sph.umich.edu) was used for prephasing and imputation (Minimac) of 
GIGA genotypes (Das et al. 2016). Imputations of BioMe genotypes were carried out with 
the program IMPUTE using the 1000 Genomes project phase I version 3 as a reference 
(Genomes Project et al. 2012; Howie et al. 2009).
Population structure
In GIGA, the population structure was examined by principal-components analysis (PCA) in 
PLINK v1.9 (Chang et al. 2015); PCA plots for each array and population are displayed in 
Supplementary Fig. 8. Scree plots were examined to determine the number of principal-
components (PC) for adjustment of potential population stratification (shown in 
Supplementary Fig. 9). The first five PCs were used as covariates for South African samples, 
the first four for Tanzanian samples.
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In BioMe, population structure (Supplementary Fig. 8) was controlled for by means of 
genetic matching using the first two PCs. Additional matching was performed based on age 
and sex.
Replication
The Eyes of Africa Genetic Consortium, the South London POAG case–control cohort and 
The African Descent and Glaucoma Evaluation Study (ADAGES III) served as replication 
panels. The Eyes of Africa Genetic consortium is a Pan-African study of genetic 
determinants of POAG, and comprises studies recruited from Ghana, Nigeria, South Africa 
and the USA, totaling a sample size of 2320 POAG cases and 2121 controls. The methods of 
ascertaining POAG cases has been described in detail elsewhere (Liu et al. 2013). In brief, 
POAG cases met the following inclusion criteria: glaucomatous optic neuropathy (VCDR > 
0.7 or notch in the neuroretinal rim), and visual field loss (examined by frequency doubling 
technology or standard automated perimetry) consistent with optic nerve damage in at least 
one eye. Controls were participants with no known first-degree relative with glaucoma, IOP 
less than 21 mmHg in both eyes without treatment, and no evidence of glaucomatous optic 
neuropathy in either eye. Genotyping of cases and controls was performed on the Illumina 
OmniExpressExome array. Genotype QC is described in Supplementary Appendix 2.
The South London POAG case–control cohort consists of 378 POAG patients and 217 
controls of West African ancestry residing in the United Kingdom. Patients were recruited 
from glaucoma clinics in South London and included if they had visual field loss in at least 
one eye attributed to glaucoma by a glaucoma specialist, had a VCDR of more than 0.6, 
were receiving intraocular-lowering medication (or had previous surgery), and had open 
drainage angles on gonioscopy. Controls were recruited from other eye clinics and were 
included if the examining ophthalmologist deemed there was no sign of POAG, had healthy 
optic discs (VCDR < 0.6), and normal intraocular pressure without any IOP-lowering 
therapy (< 20 mmHg). The majority of controls did not have formal visual field testing. 
Genotyping was performed in a single batch using Illumina’s OmniExpress array. Genotype 
QC has been described in the Supplementary Appendix 2.
The African Descent and Glaucoma Evaluation Study (ADAGESIII) is a large collection of 
African American POAG patients and healthy controls recruited at five eye centers in the US 
(La Jolla, California; New York, New York; Birmingham, Alabama; Houston, Texas; 
Atlanta, Georgia). The methods of recruitment and selection of POAG cases have been 
described previously (Zangwill et al. 2018). In brief, eligibility for inclusion as a POAG case 
required glaucomatous visual field damage defined as a pattern standard deviation or 
glaucoma hemifield test results outside normal limits. If good-quality visual fields were not 
available glaucomatous optic disc damage defined as evidence of excavation, neuroretinal 
rim thinning or notching, localized or diffuse retinal nerve fiber layer defect, or an inter-eye 
asymmetry of the vertical cup-to-disc ratio of more than 0.2 was required. Controls were 
ascertained at Wake Forest School of Medicine. Details on genotyping and QC are 
summarized in the Supplementary Appendix 2.
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Statistical analysis
We conducted a three-stage GWAS. Stage 1 was aimed at the discovery and consisted of a 
meta-analysis on summary data from GIGA and BioMe. Stage 2 included replication of 
independent and lead SNPs identified at stage 1 reaching a significance level P < 1 × 10−6. 
Stage 3 combined all results in an overall meta-analysis.
Genome-wide association testing in the GIGA study assumed an additive genetic model 
adjusting for sex and age and included the aforementioned PCs of the principal-components 
analysis. Association analyses were carried out in EPACTS (http://www.sph.umich.edu/csg/
kang/epacts/index.html) by means of the Firth bias-corrected likelihood-ratio test (Firth 
1993). In BioMe SNPTEST was applied (https://mathgen.stats.ox.ac.uk/genetics_software/
snptest/snptest.html) using the frequentist association tests implemented in the program, 
based on an additive model (Marchini et al. 2007). Cases and controls were matched by age, 
sex and the first two principal components in a 1:2 case/control ratio. To control for 
genotype uncertainty, we used the missing data likelihood score test (the score method).
Stage 1
A centralized filtering was performed on GIGA and BioMe GWAS results prior to the meta-
analysis. Summary result files were assessed and filtered for monomorphic SNPs and SNPs 
with a minor allele frequency < 0.01. SNP’s that failed or had low-quality imputation, i.e. 
Minimac r2/SNPTEST INFO < 0.5, were also excluded. The cleaned summary statistics of 
both studies were then meta-analyzed by means of an inverse variance fixed effects meta-
analysis implemented in METAL (Wilier et al. 2010). Summary statistics were corrected 
using the ‘genomic-control’ option in METAL to eliminate any residual bias. Only variants 
present in GIGA South Africa, GIGA Tanzania, as well as BioMe were taken for further 
analysis.
We searched for evidence of replication of the 15 known POAG variants found in European 
and Asian GWA studies by employing two replication strategies. First, we used the “exact” 
approach that involves only the lead significant markers. P values at each known POAG SNP 
in our study were examined and a P < 0.05 was considered as evidence for statistically 
significant replication. Next, we analyzed the transferability of SNPs by applying the “local” 
approach. All SNPs in strong LD (r2 > 0.8) with the known POAG SNP in the 1000 
Genomes European population were analyzed. For evidence of local transferability, P values 
were adjusted for the number of effective SNPs within a locus as determined by the Genetic 
Type I Error Calculator (2018) (Li et al. 2012).
To identify potential additional independent signals nearby the lead SNP in the meta-
analysis of GIGA and BioMe, we conducted a conditional analysis implemented in Genome-
wide complex trait analysis (GCTA 2018) software, using the cojo method, which performs 
conditional and joint analyses with model selection (Yang et al. 2011). The genome-wide 
meta-analysis summary statistics from the discovery stage were used as the input data. 
Within the GCTA analysis, MAF was restricted to ≥ 1% and P < 1 × 10−6. For this analysis, 
we used the GIGA Tanzania 1000 Genome phase 3 imputed data to calculate LD between 
pairwise SNPs. SNPs further than 10 Mb apart were assumed to be in LD.
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We next applied haplotype association analysis to identify POAG associated haplotypes that 
harbor the variants identified in the discovery stage with P < 1 × 10−6. The haplotype 
association analysis comprised two steps. First, pairwise measures of LD were calculated in 
Haploview to identify LD blocks (LD) (Gabriel et al. 2002). Second, significant haplotypes 
were identified using a Chi-squared test implemented in Haploview (Barrett et al. 2005).
Stage 2
SNPs put forward for replication were first assessed in each replication sample. P value 
thresholds for significance were adjusted for the number of SNPs tested by the Bonferroni 
method. Results of all five replication studies were subsequently combined in an inverse 
variance meta-analysis.
Stage 3
Finally, results from stage 1 and 2 were combined in a transethnic meta-analysis. SNPs 
showing evidence of effect heterogeneity between studies (Phet < 0.05) were analyzed using 
the Han Eskin random-effects model (Han and Eskin 2011). This analysis implemented in 
METASOFT software increases the power to detect associations under heterogeneity.
Power analysis
Power analysis was performed using the Power for Genetic Association analyses (PGA) 
package (Menashe et al. 2008). For replication of known POAG SNPs power analysis 
showed that for α = 0.05/15 tests, (Supplementary Fig. 6 red line) and minor allele 
frequencies of 0.05, 0.10, 0.25; minimal OR’s of 1.5, 1.35 and 1.25, respectively, could be 
detected at statistical significance assuming 80% power. For genome-wide analysis in the 
discovery stage, we had > 80% power given an alpha of 5 × 10−8 to detect variants with odds 
ratios of 1.89 and 3.25 for effect allele frequencies of 0.05 and 0.01, respectively 
(Supplementary Fig. 6 green line). For validation of SNPs in stage 2, we had > 80% power 
at an alpha of 0.05/3 independent SNPs = 0.017 to detect loci with odds ratios of 1.29 and 
1.7 for effect allele frequencies of 0.05 and 0.01, respectively (Supplementary Fig. 6 line 
blue line).
Bioinformatics analysis
Several bioinformatics tools to assess whether SNPs or their linked genetic variants were 
associated with a putative function that might affect patient outcomes were consulted. 
HaploReg v4.1 and the RegulomDB v1.1 that include Genotype-Tissue Expression (GTEx) 
database from the Encyclopedia of DNA Elements (ENCODE) project were used to identify 
the regulatory potential on candidate functional variants to examine the particular tracks of 
interest, such as TF-ChIP signals, DNase peaks, DNase footprints and predicted DNA 
sequence motifs for transcription factors (Boyle et al. 2012; Ward and Kellis 2012). The 
GTEx data were used to identify the correlations between SNPs and whole-blood-specific 
gene expression levels. The Ocular Tissue Database (2018) (IOWA) was checked for 
expression of associated genes in relevant ocular tissue, in which levels of gene expression 
are indicated as Affymetrix Probe Logarithmic Intensity Error (PLIER) normalized value 
[with normalization in PLIER as described in Wagner et al. 2013].
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Gene-based tests
We performed a gene-based test in VEGAS2 (Mishra and Macgregor 2015) to confirm 
known POAG genes and to identify additional loci not reaching genome-wide significance 
in a single marker-based analysis. VEGAS2 examines the association from all SNPs across a 
gene and corrects for gene size and LD between SNPs. The 1000 Genomes phase 3 African 
populations were downloaded from the VEGAS website and used as the reference panel for 
pairwise LD correlations. SNPs were allocated to one or more autosomal genes using 
customized gene boundaries of ± 10 kb.
Genetic risk score
To further evaluate to which extent known POAG SNPs confer risk in our study, a genetic 
risk score (GRS) was calculated in the GIGA dataset. Fifteen well imputed/genotyped 
(Minimac r2 > 0.5) SNPs that were previously reported in large GWAS were used for 
constructing the GRS. For each individual, a weighted GRS was computed by multiplying 
the number of effect alleles with the log (OR) reported in the literature. We assessed the 
association of the GRS with POAG in a logistic regression model adjusting for sex, age and 
PCs. An estimation of the attributable genetic risk was calculated using the R package 
“attribrisk”.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Genetic Risk Score. Genetic risk score based on the 15 known POAG-loci identified in 
Europeans and Asians GWAS (rs1192415, rs28504591, rs4619890, rs2745572, rs11969985, 
rs4236601, rs284489, rs10712703, rs2472493, rs58073046, rs7137828, rs10483727, 
rs3785176, rs9897123, rs16984299). Participants were grouped into quintiles of the genetic 
risk scores. Green circles represent the POAG odds ratio (adjusted for age, sex and principal 
components) when comparing each quintile to the lowest quintile (Q1 = reference line). The 
green-capped lines represent 95% CI of the POAG odds ratios. Bars represent the percentage 
of POAG cases (dark blue) and controls (light blue) per quintile.
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Fig. 2. 
Study design
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Fig. 3. 
Manhattan plot for the association of genome-wide SNPs with primary open-angle glaucoma 
in GIGA BioMe meta-analysis. Manhattan plot of the GWAS meta-analysis of GIGA and 
BioMe (N=1113cases/N = 1826 controls). The figure shows −log10-transformed P values 
for all SNPs. The upper dotted horizontal line represents the genome-wide significance 
threshold of P < 5.0 × 10−8; the lower dotted line indicates a P value of 1 × 10−6. Green dots 
represents variants in that are in linkage disequilibrium (r2 > 0.6 1000 Genomes African 
ancestry) with the top SNP rs141186647.
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Fig. 4. 
Regional Plots for SNPs P < 1 × 10−6 in the discovery stage (stage 1)
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Table 1
Demographic and clinical characteristics GIGA study and BioMe
Clinical and demographic characteristics POAG cases Controls
GIGA 663 476
 Median age, years (IQR) 65.0 (18) 65.0 (12)
 Female, n (%) 281 (42) 266 (56)
 Self-reported ethnicity/race, n (%)
  South African coloured 179 (27) 96 (20)
  African black 484 (73) 380 (80)
 Median proportion GAA, % (IQR)
  South African colored 33.86 (37.26) 33.12 (28.18)
  African black 97.90 (7.80) 97.28 (7.81)
BioMe 450 1350
 Median age, years (IQR) 64.0 (16) 64.0 (16)
 Female, n (%) 290 (64) 870 (64)
 Median proportion GAA, % (IQR) 86.84 (12.84) 86.74 (12.99)
GAA genetic African ancestry, IQR interquartile range, POAG primary open-angle glaucoma, SD standard deviation
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